On the hypothesis that the failing heart is energy starved: Lessons learned from the metabolism of ATP and creatine-Reference-Cited by-同舟云学术

On the hypothesis that the failing heart is energy starved: Lessons learned from the metabolism of ATP and creatine

Published:2006-11 Issue:6 Volume:8 Page:457-464
ISSN:1522-6417
Container-title:Current Hypertension Reports
language:en
Short-container-title:Current Science Inc

Author:

Ingwall Joanne S.

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11906-006-0023-x.pdf

Reference49 articles.

1. Huss JM, Kelly DP: Nuclear receptor signaling and cardiac energetics. Circ Res 2004, 95:568–578.

2. Huss JM, Kelly DP: Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest 2005, 115:547–555.

3. Ingwall JS: Transgenesis and cardiac energetics: new insights into cardiac metabolism. J Mol Cell Cardiol 2004, 37:613–623.

4. Ingwall JS, Weiss RG: Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 2004, 95:135–145.

5. Ingwall JS: Energetic basis for heart failure—causes and consequences of decreased ATP and phosphocreatine. In Heart Failure: A Companion to Braunwald’s Heart Disease. Edited by Mann D. Philadelphia: Saunders; 2004:91–108.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the adverse effects of 1,3,6,8-tetrabromo-9H-carbazole in atherosclerotic model mice by metabolomic profiling integrated with mechanism studies in vitro;Chemosphere;2024-02

2. Effects of early exercise on cardiac function and lipid metabolism pathway in heart failure;Journal of Cellular and Molecular Medicine;2023-08-31

3. Neocryptotanshinone ameliorates insufficient energy production in heart failure by targeting retinoid X receptor alpha;Biomedicine & Pharmacotherapy;2023-07

4. Myocardial Fatigue: a Mechano-energetic Concept in Heart Failure;Current Cardiology Reports;2022-03-30

5. Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure;ESC Heart Failure;2021-05-06